| Name | Title | Contact Details |
|---|
Zimmer MedizinSystems is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Advanced Reimbursement Management offers a suite of services encompassing Medicaid reimbursement. These service lines include: Medicaid Eligibility Assistance Services – ARM provides both on-site team members to assist with I/P and O/P enrollment of your Self Pay Patients in Medicaid as well as centralized eligibility support team members who do follow up work from our central business office. Accounts Receivables Management – ARM handles a variety of services from initial Medicaid claims billing to follow-up of aged claims at 60,90,120+ days. We use our clinical audit nursing staff to do our own in house reviews when submitting claims for reconsideration. This is an included part of the service at no extra charge. Clinical Auditing Services – ARM provides a variety of clinical auditing services in addition to claims review as part of A/R management. This includes RACs, Defense Audits (all payers), Stop Loss / Carve Out, Charge Hold / Lost Charge. In all situations, ARM provides trending feedback to the hospital in an effort to provide long term solutions. ARM can do both hourly pricing or contingency rate pricing, depending on your preference. Post Payment Review (Zero Balance) – ARM can review all of your Medicaid claims for variance from expected reimbursement amounts, and provide detailed trending, The best part is that we are budget positive because this is truly “found money”
Pethealth Inc. is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Lucira Health has developed an at home COVID-19 test kit that delivers PCR quality molecular accuracy in the palm of your hand in 30 minutes or less. Our technology is transforming how we reduce the spread of infectious diseases by bringing accurate, easy-to-use self-testing into the home. This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or revoked sooner.
MediBeacon was formed in 2012 specifically to acquire the optical diagnostic program from Mallinckrodt, the Pharmaceuticals business of Covidien. MediBeacon mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population. Several product concepts in these arenas are contained in the MediBeacon Intellectual Property (IP) portfolio.